A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in…

Overview of attention for article published in Biology of Blood & Marrow Transplantation, December 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 12,272 followers.

Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell #Lymphoma: http://t.co/UqhjcK4a5S

Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell #Lymphoma: http://t.co/UqhjcK4a5S

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.